Modifiable risk factors for brain arteriovenous malformations

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037923

Enrollment

Unknown

Registered

2020-09-04

Start date

2019-01-01

Completion date

Unknown

Last updated

2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain arteriovenous malformation

Interventions

Patients with brain arteriovenous malformations:N/A

Healthy control individuals:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cerebral arteriovenous malformations diagnosed by DSA or MRA; 2. Patients who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with poor general condition or serious primary disease; 2. Patients with coagulation dysfunction; 3. Informed consent unavailable.

Design outcomes

Primary

Measure	Time frame
Body mass index;Heat rate;Systolic blood pressure;Diastolic blood pressure;Triglyceride;Total cholesterol;High-density lipoprotein (HDL) cholesterol;Low-density lipoprotein (LDL) cholesterol;Apolipoprotein A;Apolipoprotein B;Homocysteine;	—

Secondary

Measure	Time frame
White blood cell count;Lymphocyte count;Platelet count;Glucose;Albumin;Creatinine;Uric acid;	—

Countries

China

Contacts

Public ContactShuo Wang

Beijing Tiantan Hospital Affiliated to Capital Medical University

captain9858@126.com+86 13801180330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026